Request Deal Involvement

Goldman Sachs completed the acquisition of a minority stake in Aragen Life Sciences from ChrysCapital.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Shardul Amarchand Mangaldas & Co

legal advisors

Shardul Amarchand Mangaldas & Co

Dimensions

financial advisors

Dimensions

Herbert Smith Freehills Kramer

legal advisors

Herbert Smith Freehills Kramer

Deloitte

financial advisors

Deloitte

Trilegal

legal advisors

Trilegal

Weber Shandwick

pr advisors

Weber Shandwick

Jefferies & Company

financial advisors

Jefferies & Company

Shardul Amarchand Mangaldas & Co

legal advisors

Shardul Amarchand Mangaldas & Co

Dimensions

financial advisors

Dimensions

or

Principals

ARAGEN LIFE SCIENCES

target

ARAGEN LIFE SCIENCES

GOLDMAN SACHS INC

bidder

GOLDMAN SACHS INC

CHRYSCAPITAL MANAGEMENT COMPANY

vendor

CHRYSCAPITAL MANAGEMENT COMPANY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Goldman Sachs completed the acquisition of a minority stake in Aragen Life Sciences from ChrysCapital.